Chemistry:Dibekacin

From HandWiki
Revision as of 06:55, 6 March 2023 by S.Timg (talk | contribs) (over-write)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Dibekacin
Dibekacin.svg
Clinical data
Trade namesPanimycin, Tokocin
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
ChEMBL
PDB ligand
Chemical and physical data
FormulaC18H37N5O8
Molar mass451.521 g·mol−1
3D model (JSmol)

Dibekacin (3',4'-dideoxykanamycin B) is an aminoglycoside antibiotic. It is a semisynthetic derivative of kanamycin developed by Hamao Umezawa and collaborators for Meiji Seika.[1][2]

It has been used in combination with sulbenicillin.[3]

References

  1. "3',4'-Dideoxy-Kanamycin B Active Against Kanamycin-Resistant Escherichia coli and Pseudomonas aeruginosa". The Journal of Antibiotics 24 (7): 485–487. July 1971. doi:10.7164/antibiotics.24.485. PMID 4998037. 
  2. "Découverte de la dibékacine et de ses aspects chimiques [Discovery of dibekacin and its chemical aspects]". La Nouvelle Presse Médicale 11 (46): 3379–84. November 1982. PMID 7155844. 
  3. "Electron microscopy of Pseudomonas aeruginosa treated with sulbenicillin and dibekacin". Tohoku J. Exp. Med. 152 (2): 119–28. June 1987. doi:10.1620/tjem.152.119. PMID 3114912.